Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-FR
Language English French
Date Updated 2019-03-19 2019-03-18
Drug Identification Number 02268825 02268825
Brand name ANGELIQ ANGELIQ
Common or Proper name drospirenone and estradiol drospirenone and estradiol
Company Name BAYER INC BAYER INC
Ingredients DROSPIRENONE ESTRADIOL DROSPIRENONE ESTRADIOL
Strength(s) 1.0MG 1.0MG 1.0MG 1.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28's 28's
ATC code G03FA G03FA
ATC description PROGESTOGENS AND ESTROGENS IN COMBINATION PROGESTOGENS AND ESTROGENS IN COMBINATION
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-03-11 2019-03-11
Actual start date
Estimated end date 2019-04-17 2019-04-17
Actual end date 2019-03-18 2019-03-18
Shortage status Resolved Actual shortage
Company comments Product is now available to market. Product is now available to market.
Health Canada comments